Riverhead Capital Management LLC grew its position in Masimo Corporation (NASDAQ:MASI) by 65.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,464 shares of the medical equipment provider’s stock after purchasing an additional 1,364 shares during the quarter. Riverhead Capital Management LLC’s holdings in Masimo Corporation were worth $316,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. NorthCoast Asset Management LLC boosted its position in shares of Masimo Corporation by 165.5% in the second quarter. NorthCoast Asset Management LLC now owns 38,801 shares of the medical equipment provider’s stock worth $3,538,000 after purchasing an additional 24,185 shares during the period. Capital Fund Management S.A. boosted its position in shares of Masimo Corporation by 559.8% in the second quarter. Capital Fund Management S.A. now owns 360,189 shares of the medical equipment provider’s stock worth $32,842,000 after purchasing an additional 305,596 shares during the period. Alliancebernstein L.P. boosted its position in shares of Masimo Corporation by 9.9% in the second quarter. Alliancebernstein L.P. now owns 139,921 shares of the medical equipment provider’s stock worth $12,758,000 after purchasing an additional 12,660 shares during the period. HPM Partners LLC bought a new position in shares of Masimo Corporation in the second quarter worth approximately $979,000. Finally, AXA boosted its position in shares of Masimo Corporation by 94.1% in the second quarter. AXA now owns 19,600 shares of the medical equipment provider’s stock worth $1,787,000 after purchasing an additional 9,500 shares during the period. Institutional investors and hedge funds own 83.21% of the company’s stock.

Masimo Corporation (MASI) opened at 84.73 on Tuesday. The stock has a 50 day moving average of $85.78 and a 200 day moving average of $90.95. Masimo Corporation has a 12-month low of $53.78 and a 12-month high of $104.71. The stock has a market cap of $4.40 billion, a P/E ratio of 13.89 and a beta of 0.84.

Masimo Corporation (NASDAQ:MASI) last released its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.12. Masimo Corporation had a net margin of 45.90% and a return on equity of 23.45%. The firm had revenue of $192.90 million for the quarter, compared to analysts’ expectations of $189.03 million. During the same quarter last year, the company earned $0.57 EPS. The firm’s revenue for the quarter was up 11.8% compared to the same quarter last year. On average, equities research analysts anticipate that Masimo Corporation will post $2.80 earnings per share for the current fiscal year.

A number of equities analysts have weighed in on MASI shares. Roth Capital upped their price target on shares of Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a research report on Wednesday, July 19th. Zacks Investment Research downgraded shares of Masimo Corporation from a “hold” rating to a “sell” rating in a report on Tuesday, July 4th. Stifel Nicolaus began coverage on shares of Masimo Corporation in a report on Monday, July 10th. They issued a “buy” rating and a $105.00 target price on the stock. BidaskClub raised shares of Masimo Corporation from a “hold” rating to a “buy” rating in a report on Wednesday, July 12th. Finally, BTIG Research raised shares of Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 target price on the stock in a report on Monday, August 14th. One analyst has rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the company. Masimo Corporation currently has an average rating of “Hold” and a consensus target price of $95.00.

ILLEGAL ACTIVITY NOTICE: This piece was first published by Daily Political and is the property of of Daily Political. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this piece can be read at https://www.dailypolitical.com/2017/09/26/masimo-corporation-masi-holdings-boosted-by-riverhead-capital-management-llc.html.

In related news, Director Sanford Fitch sold 6,000 shares of Masimo Corporation stock in a transaction on Thursday, July 13th. The shares were sold at an average price of $91.89, for a total value of $551,340.00. Following the sale, the director now owns 89,249 shares of the company’s stock, valued at approximately $8,201,090.61. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jon Coleman sold 25,000 shares of Masimo Corporation stock in a transaction on Thursday, July 20th. The shares were sold at an average price of $97.50, for a total transaction of $2,437,500.00. Following the completion of the sale, the insider now directly owns 32,201 shares in the company, valued at approximately $3,139,597.50. The disclosure for this sale can be found here. Insiders sold a total of 126,000 shares of company stock worth $11,732,930 in the last three months. 16.60% of the stock is owned by corporate insiders.

Masimo Corporation Company Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo Corporation (NASDAQ:MASI)

Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.